Cocoa inhibits platelet activation and function

American Journal of Clinical Nutrition

Volumn 72, Issue 1, 2000, Pages 30-35

  Rein, Dietrich ^b   Paglieroni, Teresa G ^b   Wun, Ted ^b   Pearson, Debra A ^b   Schmitz, Harold H ^b   Gosselin, Robert ^b   Keen, Carl L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Blood coagulation; Cardiovascular disease; CD62P; Chocolate; Cocoa beverage; Dietary polyphenols; Glycoprotein IIb IIIa complex; Hemostasis; P selectin; Platelet activation; Platelet function tests; Platelet glycoprotein; Whole blood flow cytometry

Indexed keywords

FIBRINOGEN RECEPTOR; POLYPHENOL;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CACAO; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FLOW CYTOMETRY; FOOD INTAKE; HEMOSTASIS; HUMAN; ISCHEMIC HEART DISEASE; NORMAL HUMAN; PROTEIN BINDING; THROMBOCYTE ACTIVATION;

THEOBROMA CACAO;

EID: 0033947364     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/72.1.30     Document Type: Article

References (56)

1. Yano K, Rhoads GG, Kagan A. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med 1977;297:405-9.
2. St Leger AS, Cochrane AL, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979;1:1017-20.
3. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.
4. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-7.
5. Kinsella JE, Frankel EN, German JB, Kanner J. Possible mechanisms for the protective role of antioxidants in wine and plant foods. Food Technol 1993;47:85-9.
6. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-11.
7. Hertog MG, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995;155:381-6.
8. Keli SO, Hertog MG, Feskens EJ, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 1996;156:637-42.
9. White JG. Platelets and atherosclerosis. Eur J Clin Invest 1994;24 (suppl 1):25-9.
10. Osterud B. A global view on the role of monocytes and platelets in atherogenesis. Thromb Res 1997;85:1-22.
11. Trip MD, Cats VM, van Capelle FJ, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990;322:1549-54.
12. Loscalzo J. Antiplatelet and antithrombotic effects of organic nitrates. Am J Cardiol 1992;70:18B-22B.
13. Hennekens CH, Buring JE. Aspirin in the primary prevention of cardiovascular disease. Cardiol Clin 1994;12:443-50.
14. Collins R, Peto R, Baigent C, Sleight P. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 1997;336:847-60.
15. Hennekens CH. Platelet inhibitors and antioxidant vitamins in cardiovascular disease. Am Heart J 1994;128:1333-6.
16. Hennekens CH. Aspirin in the treatment and prevention of cardiovascular disease. Annu Rev Public Health 1997;18:37-49.
17. Schafer AI. Antiplatelet therapy. Am J Med 1996;101:199-209.
18. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med 1994;330:956-61.
19. Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner BA, Michelson AD. Effect of strenuous exercise on platelet activation state and reactivity. Circulation 1993;88:1502-11.
20. Rajasekhar D, Barnard MR, Bednarek FJ, Michelson AD. Platelet hyporeactivity in very low birth weight neonates. Thromb Haemost 1947;77:1002-7.
21. Allman-Farinelli MA, Bendall L, Troy J, et al. A simple, whole blood method for assessment of platelet function: application to dietary intervention. Thromb Res 1998;90:163-9.
22. Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Am Coll Cardiol 1997;129:507-16.
23. Hammerstone JF, Lazarus SA, Mitchell AE, Rucker RB, Schmitz HH. Identification of procyanidins in cocoa and chocolate using high-performance liquid chromatography/mass spectrometry. J Agric Food Chem 1999;47:490-6.
24. Mammen EF, Comp PC, Gosselin R, et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998;24:195-202.
25. Fressinaud E, Veyradier A, Truchaud F, et al. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 1998;91:1325-31.
26. Waterhouse AL, Shirley JR, Donovan JL. Antioxidants in chocolate. Lancet 1996;348:834.
27. Kondo K, Hirano R, Matsumoto A, Igarashi O, Itakura H. Inhibition of LDL oxidation by cocoa. Lancet 1996;348:1514.
28. Sanbongi C, Osakabe N, Natsume M, Takizawa T, Gomi S, Osawa T. Antioxidative polyphenols isolated from Theobroma cacao. J Agric Food Chem 1998;46:454-7.
29. Beretz A, Cazenave JP, Anton R. Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships. Agents Actions 1982;12:382-7.
30. Landolfi R, Mower RL, Steiner M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochem Pharmacol 1984;33:1525-30.
31. Corvazier E, Maclouf J. Interference of some flavonoids and non-steroidal anti-inflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils. Biochim Biophys Acta 1985;835:315-21.
32. Folts JD, Begolli B, Shanmuganayagam D, Osman H, Maalej N. Inhibition of platelet activity with red wine and grape products. Biofactors 1997;6:411-4.
33. Osman HE, Maalej N, Shanmuganayagam D, Folts JD. Grape juice but not orange or grapefruit juice inhibits platelet activity in dogs and monkeys (Macaca fasciularis). J Nutr 1998;128:2307-12.
34. Howard MA, Coghlan M, David R, Pfueller SL. Coagulation activities of plasma microparticles. Thromb Res 1988;50:145-56.
35. Jy W, Horstman LL, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Am Coll Cardiol 1992;119:334-45.
36. Siljander P, Carpen O, Lassila R, Platelet-derived microparticles associate with fibrin during thrombosis. Blood 1996;87:4651-63.
37. Barry OP, Pratico D, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997;99:2118-27.
38. Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308:81-106.
39. Lekstrom JA, Bell WR. Aspirin in the prevention of thrombosis. Medicine 1991;70:161-78.
40. Porter LJ, Ma Z, Chan BG. Cacao procyanidins - major flavonoids and identification of some minor metabolites. Phytochemistry 1991; 30:1657-63.
41. Das NP. Studies on fluvonoid metabolism. Absorption and metabolism of (+)-catechin in man. Biochem Pharmacol 1971;20:3435-45.
42. Hackett AM, Griffiths LA, Broillet A, Wermeille M. The metabolism and excretion of (+)-[14C]cyanidanol-3 in man following oral administration. Xenobiotica 1983;13:279-86.
43. Richelle M, Tavazzi I. Enslen M, Offord EA. Plasma kinetics in man of epicatechin from black chocolate. Eur J Clin Nutr 1999;53:22-6.
44. Lee MJ, Wang ZY, Li H, et al. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev 1995;4:393-9.
45. Hollman PCH, Gaag MVD, Mengelers MJB, van Trijp JMP, deVries JHM, Katan MB. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic Biol Med 1996;21:703-7.
46. Birkett DJ, Dahlqvist R, Miners JO, Lelo A, Billing B. Comparison of theophylline and theobromine metabolism in man. Drug Metab Dispos 1985;13:725-8.
47. Ardlie NG, Glew G, Schultz, BG, Schwarzt CJ. Inhibition and reversal of platelet aggregation by methyl xanthines. Thromb Diath Haemorrh 1967;18:670-3.
48. Bak AA, Grobhee DE. Coffee, caffeine and hemostasis: a review. Neth J Med 1990;37:242-6.
49. Biaggioni I, Paul S, Puckett A, Arzubiaga C. Caffeine and theophylline as adenosine receptor antagonists in humans. J Pharmacol Exp Ther 1991;258:588-93.
50. Daly JW, Hide I, Muller CE, Shamim M. Caffeine analogs: structure-activity relationships at adenosine receptors. Pharmacology 1991;42: 309-21.
51. Coe SD, Coe MD. The true history of chocolate. New York: Thames and Hudson Inc, 1996:280.
52. Morton JF. Atlas of medicinal plants of Middle America: Bahamas to Yucatan. Vol 28. Springfield, IL: Charles C Thomas, 1981.
53. Cruz de la Martin, Badiano J, Emmart EW. The Badianus manuscript. Codex Barberini, Latin 241, Vatican Library; an Aztec herbal of 1552. Vol 24. Baltimore: Johns Hopkins Press, 1940.
54. Ortiz, de Montellano B. Aztec medicine, health, and nutrition. Vol 16. New Brunswick, NJ: Rutgers University Press, 1990.
55. Colmenero de Ledesma A, Wadsworth J. Chocolate, or, an Indian drinke: by the wise and moderate use whereof, health is preserved, sicknesse diverted and cured, especially the plague of the guts, vulgarly called the new disease. London: Printed by JG for Iohn Dakins, 1652.
56. Sanbongi C, Suzuki N, Sakane T. Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in vitro. Cell Immunol 1997;177:129-36.